Shenzhen Sijia Pharmaceutical Co., Ltd.
About Shenzhen Sijia Pharmaceutical Co., Ltd.
Certifications
Categories
-
Country/Region:China
-
On CPHI since:2025
-
Certificates:2
-
Employees:1 - 24
Company types
Primary activities
Meet us at
CPHI South East Asia 2026
QSNCC, Bangkok, Thailand
08 Jul 2026 - 10 Jul 2026
CPHI Milan 2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
Products from Shenzhen Sijia Pharmaceutical Co., Ltd. (5)
-
Product Avibactam Sodium
Avibactam sodium is an organic sodium salt that is the monosodium salt of avibactam. Used in combination with ceftazidime pentahydrate for the treatment of complicated urinary tract infections including pyelonephritis. It has a role as an EC 3.5.2.6 (beta-lactamase) inhibitor, an antibacterial drug and an ... -
Product Everolimus
Everolimus is a macrocyclic lactone that is rapamycin in which the hydroxy group attached to the cyclohexyl moiety has been converted into the corresponding 2-hydroxyethyl ether. It is an immunosuppressant and antineoplastic agent. It has a role as an antineoplastic agent, an immunosuppressive agent, a mTO... -
Product Entecavir
Our company is committed to supplying API, advanced intermediates, excipients, chemicals, together with regulatory documentation support like DMF in CTD Format, from R&D to commercial production and cGMP audit service.
-
Product Ferric Carboxymaltose
Our company is committed to supplying API, advanced intermediates, excipients, chemicals, together with regulatory documentation support like DMF in CTD Format, from R&D to commercial production and cGMP audit service.
-
Product Posaconazole
Our company is committed to supplying API, advanced intermediates, excipients, chemicals, together with regulatory documentation support like DMF in CTD Format, from R&D to commercial production and cGMP audit service.




